Allogeneic human umbilical cord-derived mesenchymal stem cells reduce lipopolysaccharide-induced inflammation and acute lung injury

Keyphrases

• Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSCs) 100%
• Acute Lung Injury 100%
• Allogeneic 100%
• Lipopolysaccharide-induced Inflammation 100%
• Human Umbilical Cord 40%
• Umbilical Cord-derived MSC 40%
• Inflammation 20%
• Inflammatory Cytokines 20%
• Mesenchymal Stem Cells 20%
• Lipopolysaccharide 20%
• Interleukin-1β 20%
• Interleukin-6 20%
• Lipopolysaccharide-induced 20%
• Intratracheal Injection 20%
• Clinical Setting 10%
• Infiltration 10%
• Mouse Model 10%
• Clinical Disease 10%
• Lung Tissue 10%
• Neutrophils 10%
• Apoptotic Cell Death 10%
• High Mortality Rate 10%
• Pharmacological Agents 10%
• ROS Production 10%
• Bronchoalveolar Lavage Fluid 10%
• Tail Vein 10%
• Inflammatory Cell Infiltration 10%
• Pulmonary Edema 10%
• Treatment Regimen 10%
• Hypoxemia 10%
• Lung Injury Score 10%
• Lung Permeability 10%
• Immunomodulating 10%
• Cell Secretion 10%
• Bacterial Endotoxin 10%

Immunology and Microbiology

• Mesenchymal Stem Cell 100%
• Umbilical Cord 100%
• Interleukin-1 33%
• Tumor Necrosis Factor 33%
• Interleukin 6 33%
• Proinflammatory Cytokine 16%
• Inflammatory Cell 16%
• Mouse Model 16%
• Inflammatory Cytokine 16%
• Neutrophil 16%
• Mortality Rate 16%
• Bronchoalveolar Lavage Fluid 16%
• Vein 16%
• Cellular Secretion 16%
• Programmed Cell Death 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Lung Injury 100%
• Lipopolysaccharide-Induced Inflammation 100%
• Cytokine 25%
• Inflammation 25%
• Tumor Necrosis Factor 25%
• Interleukin 6 25%
• Lipopolysaccharide 25%
• Lipopolysaccharide-Induced Acute Lung Injury 25%
• Mouse Model 12%
• Mortality Rate 12%
• Endotoxin 12%
• Respiratory Failure 12%
• Lung Edema 12%
• Diseases 12%